Immunoglobulins on the Surface of Hamster Lymphocytes

  • Claire P. Robles
  • Richard L. Proia
  • David A. Hart
  • Leon Eidels
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 134)


Cell surface immunoglobulin (Ig) is important as an antigen specific receptor on B lymphocytes. It is distributed in a clonotypic fashion and may also function in the antigen-dependent triggering of B lymphocytes. In most species, the predominant isotypes of cell surface Ig are 7–8S membrane IgM (mIgM) and IgD (mIgD). Evidence from experiments with mouse lymphoid cells indicates that the class of Ig present on the B cell can determine whether a cell is triggered or tolerized after exposure to specific antigen (reviewed in 1,2). Ontogenic development of cell surface Ig in the murine system begins with the appearance of mIgM-bearing cells and is followed by cells expressing both mIgM and mIgD. Immature murine B lymphocytes display predominantly mIgM at the cell surface and constitute a population of lymphocytes that are readily tolerized. In contrast, mature B cells express both mIgM and mIgD on their surface. Exposure of these mature cells to antigen leads to subsequent proliferation and differentiation to antibody secretion. Furthermore, removal of mIgD from the surface of these mature lymphocytes (by treatment with papain or capping by specific antisera) results in a population of cells that becomes preferentially tolerized by antigen (2). Thus, the two classes of surface Ig, mIgM and mIgD, appear to regulate the response of B lymphocytes to antigen presentation.


Light Chain Heavy Chain Immune Precipitate Glycoprotein Fraction Delta Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Moller, G. Immunol Rev 37 (1977) 3.CrossRefGoogle Scholar
  2. 2.
    Vitetta, E.S., et al. Biological Basis of Immunodeficiency, ed. Gelfand and Dosch. (1980) 189.Google Scholar
  3. 3.
    Coe, J.E.; Green, I. J Natl Cancer Inst 54 (1975) 269.PubMedGoogle Scholar
  4. 4.
    Sullivan, T. et al. This volume.Google Scholar
  5. 5.
    Eidels, L. et al. Molec Immunol 16 (1979) 541.CrossRefGoogle Scholar
  6. 6.
    Haustein, D. J Immunol Meth 7 (1975) 25.CrossRefGoogle Scholar
  7. 7.
    Hayman, M.; Crumpton, M.J. Biochem Biophys Res Commun 47 (1972) 923.PubMedCrossRefGoogle Scholar
  8. 8.
    Cuatrecasas, P. J Biol Chem 245 (1970) 359.Google Scholar
  9. 9.
    Hart, D.A. Infect Immun 11 (1975) 742.PubMedGoogle Scholar
  10. 10.
    Eidels, L. J Immunol 123 (1979) 846.Google Scholar
  11. 11.
    Finkleman, F.D. et al. J Immunol 116 (1976) 1173.Google Scholar
  12. 12.
    Ruddick, J.H.; Leslie, G.A. J Immunol 118 (1977) 1025.PubMedGoogle Scholar
  13. 13.
    Golding, H. et al. J Immunol 123 (1979) 2751.PubMedGoogle Scholar
  14. 14.
    McIntire, K.R.; Potter, M. J Natl Cancer Inst 33 (1964) 631.PubMedGoogle Scholar
  15. 15.
    Fahey, J.L.; Solomon, A. J Exp Med 117 (1963) 81.CrossRefGoogle Scholar
  16. 16.
    Melcher, U. et al. J Exp Med 140 (1974) 1427.PubMedCrossRefGoogle Scholar
  17. 17.
    Vitetta, E.S.; Uhr, J.W. J Immunol 117 (1976) 1579.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Claire P. Robles
    • 1
  • Richard L. Proia
    • 1
  • David A. Hart
    • 1
  • Leon Eidels
    • 1
  1. 1.Department of MicrobiologyThe University of Texas Health Science Center at DallasDallasUSA

Personalised recommendations